Coronavirus

Russia Approves Antiviral Drug Avifavir to Treat COVID-19 Patients

Akash Singh

Russian Health Ministry has approved the antiviral drug, known as Avifavir to treat coronavirus patients in all hospitals in the country. It is expected that this will reduce the pressure on the country's health system. With this, there will be a decrease in the number of corona infected patients in the country. The head of Russia's RDIF Sovereign Wealth Fund said in an interview that the drug would be manufactured to treat about 60,000 people a month. Now it will be interesting to see how effective this drug will be for Corona patients. Explain that Russia has allowed a modified version of Japanese medicine. However, Japan has not yet approved the use of this medicine.

Image credit: Reuters
Image credit: Reuters

At present, there is no vaccine for coronavirus in the world. Although the whole world is engaged in the discovery of the Coronavirus vaccine, these drugs have not yet shown any effect in human trials. Human test results of vaccines were not encouraging. In such a situation, a new antiviral drug 'Remdesivir' is quite promising. It is being claimed that drug testing has shown limited effects of preventing corona infection. Corona patients are being given this medicine in many countries of the world.

Devastation Wreaked by Torrential Rain in Brazil, 29 Dead; Over 60 Missing

Lok Sabha Elections 2024: Will KL Sharma Save Congress's Traditional Seat or Will Smriti Claim Amethi? Understand the Dynamics

RPSC Announces Proposed Dates for 6 Different Competitive Exams, See Details

CBSE Class 10th Result 2024: When and Where to Download the Scorecard

Beat the Heat: Foods to Keep You Cool and Hydrated in Summer Season